The UK’s four Chief Medical Officers and NHS England and Improvements’ National Medical Director have written a joint letter to every NHS trust in the country urging them to continue to recruit high numbers of COVID-19 patients into the RECOVERY trial.
A pioneering breast cancer therapy requiring just one shot of radiotherapy rather than conventional weeks-long treatment, has proven to be as effective for most women in treating the disease, finds research funded and supported by NIHR.
As the number of people registered to take part in COVID-19 vaccine trials has now topped 100,000, we are encouraging others to follow their lead to help speed up efforts to discover safe and effective vaccines.
Breast screening women aged 40-49 reduces breast cancer mortality with minimal increased overdiagnosis, finds NIHR-funded research that looked at data from 160,000 women.
An update on the implementation of the Restart Framework
The NIHR has today reaffirmed its long-standing commitment to transparency by supporting the Health Research Authority’s new transparency strategy, which aims to ensure information about health and social care research is made publicly available in a way that benefits patients, researchers and policy makers.
Patients with frailty, older age and urinary tract infections (UTIs) are at greatest risk of developing sepsis following infection consultations in primary care, NIHR-funded research finds.
The NIHR has signed an agreement between research funders and employers to improve the employment and support for researchers and research careers in higher education in the UK.
Study shows no statistical difference in live birth and pregnancy rates in women under 38 who had endometrial scratch before first IVF or ICSI (intra-cytoplasmic sperm injection) treatment compared to those who only received conventional treatment.
New guidance from the Department of Health and Social Care (DHSC) sets out the process by which non-NHS organisations that have loaned/redeployed research staff to the NHS during the COVID-19 pandemic can recover the cost.
Premature babies with serious brain haemorrhage treated with a novel surgical technique were twice as likely to survive without severe learning disability 10 years later, when compared with infants given standard treatment, NIHR-funded research finds.
An update on the implementation of the Restart Framework
The NIHR supported Vivaldi study has today published data from a large scale survey which looked at coronavirus (COVID-19) infections in care homes providing care for dementia patients and the elderly in England.
Read the latest performance figures for the NIHR Clinical Research Network for 2019/2020
A new study has been funded to analyse samples from 20,000 people with myalgic encephalomyelitis (ME) to search for genetic differences that may indicate underlying causes or increase the risk of developing the condition.
The NIHR-funded and supported study RECOVERY (Randomised Evaluation of COVid-19 thERapY) has today announced that the steroid dexamethasone has been identified as the first drug to improve survival rates in certain coronavirus patients.
The RECOVERY-RS trial is rolling out across the UK, looking to identify safe and effective alternatives to treatment using a ventilator.
Over 100,000 UK participants have now enrolled in COVID-19 urgent public health research supported by the NIHR - at NHS hospitals and care settings across the United Kingdom.
A new UK-wide clinical trial, offering an innovative cell therapy treatment for COVID-19 patients with acute respiratory failure has recruited its first patients, supported by NIHR.
Black Lives Matter. We recognise the problem of racism and structural barriers to minority communities in the research system.
An NIHR funded study provides new insight for clinicians such as GPs and pharmacists, to help them manage their patients’ medication more effectively.
Professor Robert Peveler has been appointed Clinical Director for NHS Engagement at the NIHR Clinical Research Network.
The first four arms of ACCORD have now recruited and enrolled COVID-19 patients. Recruitment is ongoing and is being encouraged across sites in the UK as each arm seeks to enroll around 60 patients.
A new treatment is available to patients in the NHS following the successful results of trials being conducted in the UK using the anti-viral drug remdesivir.
A UK-wide group of clinical academic trainee funders, including the NIHR, has developed a series of principles to support those returning to clinical academic roles.
